\setlength{\LTpost}{0mm}
\begin{longtable}{llrrrrr}
\toprule
\multicolumn{2}{c}{ATC sub-group} & \multicolumn{3}{c}{Cox hazard risk (HR) estimates} & \multicolumn{2}{c}{\# of users} \\ 
\cmidrule(lr){1-2} \cmidrule(lr){3-5} \cmidrule(lr){6-7}
symbol & description & HR & 95\% CI & FDR p-value\textsuperscript{\textit{1}} & non-PD users & PD users \\ 
\midrule
\multicolumn{7}{l}{drugs decreasing PD risk} \\ 
\midrule
N07 & Other Nervous System Drugs & $0.60$ & $0.51$–$0.71$ & $2.59 \times 10^{-7}$ & $61,244$ & $113$ \\ 
H02 & Corticosteroids For Systemic Use & $0.85$ & $0.79$–$0.91$ & $3.09 \times 10^{-5}$ & $250,596$ & $924$ \\ 
C09 & Agents Acting On The Renin-Angiotensin System & $0.90$ & $0.86$–$0.94$ & $3.62 \times 10^{-5}$ & $491,366$ & $3,418$ \\ 
R03 & Drugs For Obstructive Airway Diseases & $0.87$ & $0.82$–$0.93$ & $1.69 \times 10^{-4}$ & $271,161$ & $1,265$ \\ 
S03 & Ophthalmological And Otological Preparations & $0.84$ & $0.75$–$0.93$ & $2.87 \times 10^{-2}$ & $74,330$ & $321$ \\ 
L04 & Immunosuppressants & $0.77$ & $0.65$–$0.91$ & $3.11 \times 10^{-2}$ & $43,299$ & $138$ \\ 
\midrule
\multicolumn{7}{l}{drugs increasing PD risk} \\ 
\midrule
N06 & Psychoanaleptics & $2.03$ & $1.93$–$2.13$ & $5.61 \times 10^{-172}$ & $264,446$ & $2,010$ \\ 
G04 & Urologicals & $1.43$ & $1.37$–$1.49$ & $3.13 \times 10^{-55}$ & $386,265$ & $3,252$ \\ 
N05 & Psycholeptics & $1.36$ & $1.30$–$1.42$ & $4.27 \times 10^{-41}$ & $461,737$ & $3,009$ \\ 
A06 & Drugs For Constipation & $1.52$ & $1.38$–$1.68$ & $1.60 \times 10^{-14}$ & $69,804$ & $333$ \\ 
S01 & Ophthalmologicals & $1.19$ & $1.14$–$1.25$ & $3.56 \times 10^{-13}$ & $459,353$ & $2,763$ \\ 
N03 & Antiepileptics & $1.38$ & $1.27$–$1.50$ & $3.86 \times 10^{-13}$ & $113,327$ & $601$ \\ 
A11 & Vitamins & $1.29$ & $1.20$–$1.38$ & $8.19 \times 10^{-11}$ & $164,289$ & $877$ \\ 
B01 & Antithrombotic Agents & $1.15$ & $1.10$–$1.20$ & $9.43 \times 10^{-9}$ & $512,239$ & $4,512$ \\ 
D01 & Antifungals For Dermatological Use & $1.21$ & $1.13$–$1.29$ & $1.80 \times 10^{-7}$ & $198,537$ & $1,019$ \\ 
C07 & Beta Blocking Agents & $1.13$ & $1.08$–$1.18$ & $2.57 \times 10^{-6}$ & $365,359$ & $3,172$ \\ 
H01 & Pituitary And Hypothalamic Hormones And Analogues & $1.96$ & $1.53$–$2.51$ & $3.29 \times 10^{-6}$ & $5,096$ & $64$ \\ 
C01 & Cardiac Therapy & $1.16$ & $1.09$–$1.23$ & $1.66 \times 10^{-5}$ & $162,359$ & $1,391$ \\ 
B03 & Antianemic Preparations & $1.17$ & $1.09$–$1.25$ & $1.69 \times 10^{-4}$ & $155,359$ & $900$ \\ 
A02 & Drugs For Acid Related Disorders & $1.10$ & $1.04$–$1.15$ & $5.89 \times 10^{-3}$ & $394,568$ & $2,079$ \\ 
A12 & Mineral Supplements & $1.16$ & $1.06$–$1.28$ & $2.08 \times 10^{-2}$ & $91,303$ & $487$ \\ 
R06 & Antihistamines For Systemic Use & $1.10$ & $1.04$–$1.17$ & $2.08 \times 10^{-2}$ & $315,034$ & $1,309$ \\ 
G03 & Sex Hormones And Modulators Of The Genital System & $1.33$ & $1.11$–$1.58$ & $3.19 \times 10^{-2}$ & $23,846$ & $122$ \\ 
N02 & Analgesics & $1.07$ & $1.02$–$1.11$ & $4.58 \times 10^{-2}$ & $770,497$ & $3,459$ \\ 
\bottomrule
\end{longtable}
\begin{minipage}{\linewidth}
\textsuperscript{\textit{1}}p-value adjusted for false discovery rate\\
\end{minipage}

